Filing Details
- Accession Number:
- 0001209191-14-058791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-19 16:47:28
- Reporting Period:
- 2014-09-17
- Filing Date:
- 2014-09-19
- Accepted Time:
- 2014-09-19 16:47:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-17 | 5,200 | $11.27 | 344,095 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-17 | 800 | $92.75 | 343,295 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-17 | 3,500 | $93.61 | 339,795 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-17 | 900 | $94.43 | 338,895 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-17 | 5,200 | $0.00 | 5,200 | $11.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,900 | 2014-10-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,286 | Indirect | 401(k) |
Common Stock | 300,000 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $92.75 (range $92.12 to $93.10).
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $93.61 (range $93.17 to $94.04).
- Open market sales reported on this line occurred at a weighted average price of $94.43 (range $94.18 to $94.70).
- Common stock held in grantor retained annuity trusts.
- Fully vested.